Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-12-15

Clinical Trial Update: Magnesium Supplementation to Prevent Bone Loss [Phase 1]

View source ↗

Summary

This Phase 1 trial investigating magnesium supplementation to prevent bone loss in osteoporosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Magnesium supplement (Magnesium)

Snippet

Sponsor: University of Tennessee | Conditions: Osteoporosis | Phase 1 | Status: COMPLETED